University of Twente Student Theses

Login

Using multi-criteria decision analysis to evaluate the potential of biosimilars to lower costs in oncology

Tuenter, Hilde (2015) Using multi-criteria decision analysis to evaluate the potential of biosimilars to lower costs in oncology.

[img] PDF
1MB
Abstract:Even though biosimilars have the potential to bend down the cost curve of oncology by at least 10 percent, their actual uptake appeared to be less evident than expected. Currently, both patients and healthcare providers are not confident about the efficacy, safety and interchangeability of biosimilars compared with their reference product. The limited knowledge regarding biosimilars in oncology may have an impact on the attitudes and perceptions of stakeholders in oncology. To evaluate the potential of biosimilars to lower costs in oncology, it is important to determine the preferences of stakeholders in oncology for biosimilars. A multi-criteria decision analysis is designed to determine which factors stakeholders consider to be important with regard to the uptake of biosimilars in the Dutch oncology setting, to prioritize the role of post-marketing studies.
Item Type:Essay (Master)
Faculty:BMS: Behavioural, Management and Social Sciences
Subject:44 medicine
Programme:Health Sciences MSc (66851)
Link to this item:http://purl.utwente.nl/essays/67953
Export this item as:BibTeX
EndNote
HTML Citation
Reference Manager

 

Repository Staff Only: item control page